fluoxetine has been researched along with Atrophy in 8 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
Excerpt | Relevance | Reference |
---|---|---|
"To further explore the underlying antidepressant mechanism of ginseng total saponins (GTS), this study observed the effects on hippocampal astrocyte structural plasticity and hippocampal volume in the corticosterone-induced mouse depression model." | 7.85 | Preventive Effects of Ginseng Total Saponins on Chronic Corticosterone-Induced Impairment in Astrocyte Structural Plasticity and Hippocampal Atrophy. ( Chen, L; Dai, JG; Huang, YF; Lin, ZX; Wang, X; Zhao, YN, 2017) |
"To study the effect of fluoxetine on dendrite atrophy of hippocampal neurons in rat depression model." | 7.71 | Fluoxetine inhibits dendrite atrophy of hippocampal neurons by decreasing nitric oxide synthase expression in rat depression model. ( Luo, L; Tan, RX, 2001) |
"To further explore the underlying antidepressant mechanism of ginseng total saponins (GTS), this study observed the effects on hippocampal astrocyte structural plasticity and hippocampal volume in the corticosterone-induced mouse depression model." | 3.85 | Preventive Effects of Ginseng Total Saponins on Chronic Corticosterone-Induced Impairment in Astrocyte Structural Plasticity and Hippocampal Atrophy. ( Chen, L; Dai, JG; Huang, YF; Lin, ZX; Wang, X; Zhao, YN, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, L | 2 |
Wang, X | 1 |
Lin, ZX | 1 |
Dai, JG | 1 |
Huang, YF | 1 |
Zhao, YN | 1 |
Zhao, Y | 1 |
Lin, Z | 1 |
Ouyang, L | 1 |
Gu, L | 1 |
Chen, F | 1 |
Zhang, Q | 1 |
Morais, M | 1 |
Santos, PA | 1 |
Mateus-Pinheiro, A | 1 |
PatrĂcio, P | 1 |
Pinto, L | 1 |
Sousa, N | 1 |
Pedroso, P | 1 |
Almeida, S | 1 |
Filipe, A | 1 |
Bessa, JM | 1 |
Jin, P | 1 |
Yu, HL | 1 |
Zhang, F | 1 |
Quan, ZS | 1 |
Fontenelle, LF | 1 |
Leite, MA | 1 |
Hoexter, MQ | 1 |
Dougherty, DD | 1 |
Shavitt, RG | 1 |
D'Alcante, CC | 1 |
Duran, FL | 1 |
Lopes, AC | 1 |
Diniz, JB | 1 |
Batistuzzo, MC | 1 |
Evans, KC | 1 |
Bressan, RA | 1 |
Busatto, GF | 1 |
Miguel, EC | 1 |
Mendhekar, DN | 1 |
Luo, L | 1 |
Tan, RX | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Group Cognitive Behavioral Therapy Versus Fluoxetine for Obsessive-Compulsive Disorder: a Randomized Open Trial for Any Patient.[NCT00680602] | Phase 4 | 158 participants (Actual) | Interventional | 2006-01-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for fluoxetine and Atrophy
Article | Year |
---|---|
Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive-compulsive disorder.
Topics: Adult; Atrophy; Cognitive Behavioral Therapy; Female; Fluoxetine; Humans; Male; Nerve Fibers, Unmyel | 2013 |
7 other studies available for fluoxetine and Atrophy
Article | Year |
---|---|
Preventive Effects of Ginseng Total Saponins on Chronic Corticosterone-Induced Impairment in Astrocyte Structural Plasticity and Hippocampal Atrophy.
Topics: Animals; Antidepressive Agents; Astrocytes; Atrophy; Corticosterone; Depression; Disease Models, Ani | 2017 |
Hippocampal astrocyte atrophy in a mouse depression model induced by corticosterone is reversed by fluoxetine instead of benzodiazepine diazepam.
Topics: Animals; Antidepressive Agents; Astrocytes; Atrophy; Corticosterone; Depressive Disorder; Diazepam; | 2018 |
The effects of chronic stress on hippocampal adult neurogenesis and dendritic plasticity are reversed by selective MAO-A inhibition.
Topics: Animals; Atrophy; Carbazoles; Dendrites; Dose-Response Relationship, Drug; Fluoxetine; Hippocampus; | 2014 |
Antidepressant-like effects of oleoylethanolamide in a mouse model of chronic unpredictable mild stress.
Topics: Adrenocorticotropic Hormone; Animals; Antidepressive Agents; Antioxidants; Atrophy; Brain-Derived Ne | 2015 |
Treatment-resistant self-mutilation, tics, and obsessive-compulsive disorder in neuroacanthocytosis: a mouth guard as a therapeutic approach.
Topics: Adult; Antipsychotic Agents; Atrophy; Caudate Nucleus; Clonazepam; Clozapine; Dibenzothiazepines; El | 2008 |
Fluoxetine-induced breast atrophy.
Topics: Adult; Atrophy; Breast; Dysthymic Disorder; Female; Fluoxetine; Humans; Selective Serotonin Reuptake | 2004 |
Fluoxetine inhibits dendrite atrophy of hippocampal neurons by decreasing nitric oxide synthase expression in rat depression model.
Topics: Animals; Antidepressive Agents, Second-Generation; Atrophy; Dendrites; Depression; Fluoxetine; Hippo | 2001 |